International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.12787765
Original Research Article
Clinical Study of Determinants of Maternal Hemoglobin Levels in Relation to Low Birth Weight in Teritiary Care Centre
Published
Dec. 26, 2024
Abstract

In 2020, the incidence of low birth weight (LBW) was 27.6%. The high rates of neonatal morbidity and mortality in our country are largely attributed to factors such as poor nutrition, inadequate healthcare, and limited education for female children, early teenage marriages, frequent pregnancies, maternal malnutrition, fewer antenatal visits, and a history of adverse obstetric outcomes. These factors significantly contribute to the increased prevalence of LBW. The aim of this study was to explore the relationship between maternal haemoglobin levels and LBW.A hospital-based cross-sectional study was conducted on a total of 420 babies born at Sri Siddhartha Medical College and Hospital Research Centre in Tumkur over a period of 24 months. The study found that haemoglobin levels, and iron and folic acid supplementation were all positively associated with low birth weight (LBW) babies. The occurrence of low birth weight (LBW) is influenced by multiple maternal factors, highlighting the complexity of its causes. To reduce LBW rates, it is essential to address these factors through health education, socioeconomic development, and improving maternal nutrition during pregnancy.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
1935 Views
146 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved